Geresnis atsistatymas siejamas su maesniu oksidaciniu stresu ir efektyvesne lsteli apsauga
Recent studies have explored small-molecule inducers, selenium-based compounds, and targeted nanodelivery approaches to restore GPX4 function or mimic its antioxidant capacity in ferroptosis-prone diseases, with therapeutic implications for OA and beyond ( In summary, GPX4 acts not only as a terminal antioxidant enzyme but also as a hub that integrates transcriptional, post-transcriptional, and nutritional cues
This work was supported by GKLCDSM-20240101-02
Lets pretend that these medications were free of charge
Forte A, Baldessarini RJ, Tondo L, Vzquez GH, Pompili M, Girardi P